C O V E R S T O R Y
patients or applying previously unexplored therapies shaping its diagnostic and treatment strategies . With an extensive genomic database which has identified around 30 to 40 million unique Indian variants , significantly enhances the accuracy and precision of its diagnostic reports .
Today , Genomics has emerged as one of the best ways to understand ailments and manage the therapy of some rare diseases and oncology and run the pro-active surveillance of risky populations .
Diverse Product Portfolio
MedGenome provides comprehensive genetic and molecular tests across multiple diseases , genetics , and lifestyle conditions - Actia ( Inherited Genetics ), Prima ( Cancer Genetics ), Claria ( Reproductive Genetics ), Micra ( Infectious Disease Genetics ) and Genessense ( D2C wellness tests ).
MedGenome ’ s research services are largely driven through its US office in Foster City , California . It provides high end sequencing and bioinformatics services to academic institutions and pharmaceutical companies . The research team has been leveraging its expertise in sequencing and analysis for drug discovery research . The exclusive access to Indian population genetic data over the years has helped it conduct Indian population-based disease research programs in various disease areas such as diabetes , autoimmunity , eye diseases , cardiology etc . Its research services help provide insights into complex diseases for drug discovery .
Cracking the Competition
Dr Vedam Ramprasad , PhD , CEO , MedGenome explains the company ’ s long-term vision : “ Our dedication to scientific advancement is evident in our commitment to long-term affordability through meticulously crafted , science-driven solutions . With a focus on positioning Indian genomics globally , our solutions caters to diverse markets worldwide . Our expertise in data analytics enables the in-house development of a diverse range of tests at a fast pace catering to the dynamic needs of the medical community . We are a science driven company with a focus on finding treatment and management for critical diseases , both communicable and non-communicable diseases such as cancer , rare diseases , tuberculosis , muscular dystrophy etc .”
“ While improving healthcare management for India , MedGenome also consciously worked on improving healthcare access and affordability for emerging consumers and developing an ecosystem that is more reflective of the consumers that global healthcare seeks to serve . MedGenome has built a complimentary business model that leverages India & South Asia ’ s unique founder populations to provide genetic diagnostics and enable genomics research . With phenotypic and
18
BioVoiceNews | March / April 2024